449 related articles for article (PubMed ID: 23597304)
1. New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors.
Greig NH; Reale M; Tata AM
Recent Pat CNS Drug Discov; 2013 Aug; 8(2):123-41. PubMed ID: 23597304
[TBL] [Abstract][Full Text] [Related]
2. Muscarinic acetylcholine receptors: new potential therapeutic targets in antinociception and in cancer therapy.
Tata AM
Recent Pat CNS Drug Discov; 2008 Jun; 3(2):94-103. PubMed ID: 18537768
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological approaches to targeting muscarinic acetylcholine receptors.
Matera C; Tata AM
Recent Pat CNS Drug Discov; 2014; 9(2):85-100. PubMed ID: 25413004
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic receptor agonists and antagonists in the treatment of Alzheimer's disease.
Clader JW; Wang Y
Curr Pharm Des; 2005; 11(26):3353-61. PubMed ID: 16250841
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic M(1) agonists in the treatment of Alzheimer's disease.
Korczyn AD
Expert Opin Investig Drugs; 2000 Oct; 9(10):2259-67. PubMed ID: 11060805
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic opportunities for muscarinic receptors in the central nervous system.
Felder CC; Bymaster FP; Ward J; DeLapp N
J Med Chem; 2000 Nov; 43(23):4333-53. PubMed ID: 11087557
[No Abstract] [Full Text] [Related]
7. Muscarinic acetylcholine receptors as CNS drug targets.
Langmead CJ; Watson J; Reavill C
Pharmacol Ther; 2008 Feb; 117(2):232-43. PubMed ID: 18082893
[TBL] [Abstract][Full Text] [Related]
8. On the physiological relevance of muscarinic acetylcholine receptors in Alzheimer's disease.
Koch HJ; Haas S; Jürgens T
Curr Med Chem; 2005; 12(24):2915-21. PubMed ID: 16305479
[TBL] [Abstract][Full Text] [Related]
9. Targeting Muscarinic Acetylcholine Receptors for the Treatment of Psychiatric and Neurological Disorders.
Moran SP; Maksymetz J; Conn PJ
Trends Pharmacol Sci; 2019 Dec; 40(12):1006-1020. PubMed ID: 31711626
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic receptor subtypes in neuronal and non-neuronal cholinergic function.
Eglen RM
Auton Autacoid Pharmacol; 2006 Jul; 26(3):219-33. PubMed ID: 16879488
[TBL] [Abstract][Full Text] [Related]
11. Novel regulatory systems for acetylcholine release in rat striatum and anti-Alzheimer's disease drugs.
Muramatsu I; Uwada J; Yoshiki H; Sada K; Lee KS; Yazawa T; Taniguchi T; Nishio M; Ishibashi T; Masuoka T
J Neurochem; 2019 Jun; 149(5):605-623. PubMed ID: 30968952
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin.
Cassel JC; Jeltsch H; Neufang B; Lauth D; Szabo B; Jackisch R
Brain Res; 1995 Dec; 704(2):153-66. PubMed ID: 8788910
[TBL] [Abstract][Full Text] [Related]
13. Analgesic Effects Mediated by Muscarinic Receptors: Mechanisms and Pharmacological Approaches.
De Angelis F; Tata AM
Cent Nerv Syst Agents Med Chem; 2016; 16(3):218-226. PubMed ID: 26931765
[TBL] [Abstract][Full Text] [Related]
14. Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy.
Verma S; Kumar A; Tripathi T; Kumar A
J Pharm Pharmacol; 2018 Aug; 70(8):985-993. PubMed ID: 29663387
[TBL] [Abstract][Full Text] [Related]
15. Manipulation of the cholinergic system.
Geroldi C; Bianchetti A; Trabucchi M
Funct Neurol; 1997; 12(3-4):187-91. PubMed ID: 9218975
[No Abstract] [Full Text] [Related]
16. Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease.
Fisher A
Neurotherapeutics; 2008 Jul; 5(3):433-42. PubMed ID: 18625455
[TBL] [Abstract][Full Text] [Related]
17. Altered hippocampal muscarinic receptors in acetylcholinesterase-deficient mice.
Volpicelli-Daley LA; Duysen EG; Lockridge O; Levey AI
Ann Neurol; 2003 Jun; 53(6):788-96. PubMed ID: 12783426
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic receptor ligands and their therapeutic potential.
Eglen RM; Choppin A; Dillon MP; Hegde S
Curr Opin Chem Biol; 1999 Aug; 3(4):426-32. PubMed ID: 10419852
[TBL] [Abstract][Full Text] [Related]
19. Muscarinic drugs affect cholinesterase activity and development of eye structures during early chick development.
Angelini C; Costa M; Morescalchi F; Cimoli G; Coniglio L; Falugi C
Eur J Histochem; 1998; 42(4):309-20. PubMed ID: 10068904
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of oral chlorpyrifos exposure on cholinesterase activity and muscarinic receptor binding in neonatal and adult rat heart.
Howard MD; Mirajkar N; Karanth S; Pope CN
Toxicology; 2007 Sep; 238(2-3):157-65. PubMed ID: 17644233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
